HIV/AIDS Therapy

Once-daily HIV Medications pave way for simplified combination drug regimens

Published in Drug Week, September 6th, 2002

A once-daily drug regimen comprising three leading anti-HIV medications may allow HIV patients, who previously followed complicated, multidose drug regimens, to create a once-daily combination therapy to reduce the frequency of dosing of their HIV treatment.

The combination of the once-daily formulations of videx EC (didanosine, ddI), Epivir (lamivudine, 3TC [GlaxoSmithKline]), and Sustiva (efavirenz) therapy provides a new option for simplifying patients' medication schedules. Each drug is strongly recommended by the U.S. Department of Health and Human Services (DHHS) guidelines for use in first-line combination treatment of HIV-infected individuals.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2002-09-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry